Pro-Dex (NASDAQ:PDEX – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Monday.
Pro-Dex Trading Down 2.6 %
Shares of Pro-Dex stock traded down $0.47 during trading on Monday, hitting $17.78. The stock had a trading volume of 24,702 shares, compared to its average volume of 8,064. The stock has a 50 day simple moving average of $17.81 and a 200 day simple moving average of $18.09. The company has a market capitalization of $60.81 million, a PE ratio of 30.66 and a beta of 0.55. The company has a quick ratio of 2.08, a current ratio of 3.45 and a debt-to-equity ratio of 0.25. Pro-Dex has a 1 year low of $14.51 and a 1 year high of $22.99.
Pro-Dex (NASDAQ:PDEX – Get Free Report) last released its earnings results on Thursday, February 8th. The medical instruments supplier reported $0.14 earnings per share for the quarter. The business had revenue of $12.59 million for the quarter. Pro-Dex had a net margin of 4.13% and a return on equity of 6.50%.
Institutional Trading of Pro-Dex
Pro-Dex Company Profile
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Featured Articles
- Five stocks we like better than Pro-Dex
- Where Do I Find 52-Week Highs and Lows?
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Value Stocks You Can Buy Before They Become Big
- ESG Stocks, What Investors Should Know
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.